Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter studyIrma Kluijt, Anna Jakubowska, Dominik Rozkrut et al.|British Journal of Cancer|2012Cited by 38
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)Ruth Gershoni‐Baruch, Guillermo Pita, Paolo Peterlongo et al.|British Journal of Cancer|2009Cited by 14